Reveleer Acquires Novillus to Expand Its AI-Powered Clinical Intelligence and Quality Solutions
Acquisition Strengthens Provider Engagement, Care Gap Management, and Compliance Solutions to Improve Health Outcomes and Financial Performance
As the importance of Medicare Advantage Star Rating intensifies, and the healthcare industry increasingly emphasizes stronger alignment between payers and providers to succeed in value-based care, the acquisition positions Reveleer to further empower its customers to adapt and excel in a shifting value-based care environment. Novillus' technology will accelerate Reveleer's strategy of delivering modern, easy-to-use solutions that enable seamless collaboration between payers and providers for risk adjustment, quality improvement, and other patient improvement efforts. This includes the ability to pinpoint care gaps and performance trends at the provider group level to improve their education.
"By acquiring Novillus, we're accelerating our strategy of aligning payers and providers to improve health outcomes through faster care gap closure," said
Novillus' technologies will extend Reveleer's unique ability to bring payers and providers together through enhanced AI automation, real-time roster management, and advanced provider engagement workflows. Its Clean Provider Data solution strengthens regulatory compliance by supporting consistent adherence to the federal No Surprises Act and other regulations, reducing risk, improving directory accuracy, enhancing patient satisfaction, and minimizing provider abrasion.
The acquisition will deliver immediate value for both Reveleer and Novillus customers: health plans gain access to expanded, year-round patient improvement capabilities, while Novillus users can leverage a broader suite of value-based care solutions, enhanced resources, and AI-powered innovations to scale their impact.
"Our shared vision is to revolutionize how health plans and providers use data to drive better outcomes," said
The combined company will serve 72 million covered lives and work with 86 leading healthcare organizations across the
"Over the past three years, Reveleer has taken a strategic approach to broadening its offerings and building out one of the most comprehensive value-based care platforms on the market," said
To learn more, visit www.reveleer.com.
About Reveleer
As the industry's pioneering value-based care (VBC) technology platform, Reveleer is purpose-built to solve the most pressing real-world challenges faced by providers and health-plan organizations today. By unifying retrieval, clinical intelligence, risk adjustment, quality improvement, and member management solutions into one intelligent, AI-powered system, Reveleer streamlines fragmented workflows to supercharge productivity, enhance care quality, and optimize performance on high-priority value-based initiatives. To learn more about Reveleer's value-based care platform, visit us at Reveleer.com.
About Novillus
Novillus was founded in 2015 on the belief that it should be easier for health plans to collaborate with their provider group partners to drive improved outcomes for patients and improve health plan performance. The Company solves complex payer and provider group workflow and collaboration challenges with digital solutions and omni-channel engagement expertise. Novillus's comprehensive approach improves outcomes for all lines of business, including Medicare and associated Star Rating, Medicaid, ACA, with full support for quality and risk adjustment gaps and an integrated display of incentives.
View original content to download multimedia:https://www.prnewswire.com/news-releases/reveleer-acquires-novillus-to-expand-its-ai-powered-clinical-intelligence-and-quality-solutions-302432492.html
SOURCE Reveleer
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Charter Announces Expiration And Final Results Of Debt Exchange Offers
- Coway Honored at IDEA Design Awards 2026, Secures International Design 'Grand Slam'
- $1.30 Target Returns as XRP Price Prediction Turns Bullish, AlphaPepe Pushes Past $2.42M in Stage 20
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share